DreamerGuy Posted - 5 hours ago

$KYMR

Epawlow8 Posted - 2 days ago

$KYMR Stephens initiates coverage with overweight rating; PT $65

FlynancialAnalyst Posted - 1 week ago

$KYMR $3.30B mc $XBI #ShortSqueeze screen result with a ~3yr high wkly close on volume off key $40 level & rising 40 wk SMA Short float % in a long-term downtrend, and approaching 2yr lows of 20.61%. A squeeze could easily send this to ATHs TrendEdge.app/asset/KYMR

Tumble51 Posted - 1 week ago

$AGIO Finally a 3B dollar MC ….when $KYMR had it long ago, on FCUKIN PRE PRECLINICALS only

Tumble51 Posted - 2 weeks ago

$AGIO gee. Will wonders ever happen again here. Haha ..there was follow thru There should be a celebration after 1700 days of RED. Being priced above that preclinical POS , over valued MC of $KYMR …no drugs , no nothing is about fcukin time !

NakadasuTellaria Posted - 2 weeks ago

WIMI Hologram Cloud( $WIMI) had $5.00 Average Target Price from Evaluate Research Kymera Therapeutics, Inc. ( $KYMR) Receives $49.00 Consensus Target Price from Analysts Prosperity Bancshares, Inc. ( $PB) Receives $77.27 Consensus Target Price from Analysts Canadian Solar Inc. ( $CSIQ) Receives $23.33 Consensus Target Price from Brokerages 10x Genomics, Inc. ($TXG) Receives $30.60 Consensus Target Price from Analysts

DonCorleone77 Posted - 2 weeks ago

$AZN $KYMR $VIR $ALNY $IVVD U.S. drugmakers shifting away from Chinese supply-chain partners, WSJ says U.S. drugmakers and biotechs rely on Chinese partners for manufacturing, research, and ingredients, but, with geopolitical tensions rising, companies are now looking for alternatives, Jared Hopkins and Clarence Leong of The Wall Street Journal reports. Pharmaceutical and biotechnology companies of all side are saying it's time to reduce China risk. Industry officials, however, note one consequence of this move may be slower drug rollouts and higher costs in the U.S. Companies making this move include AstraZeneca (AZN), Kymera Therapeutics (KYMR), Amicus Therapeutics (FOLD), Vir Biotechnology (VIR), Alnylam Pharmaceuticals (ALNY), Invivyd (IVVD).

Wrangler4 Posted - 10/31/24

$KYMR About time this pos went where it belongs…it is all PRECLINICAL, meaning light years to see $42

Wrangler4 Posted - 10/30/24

$BA $HP $KYMR $NXPI $WIMI KYMR. Overvalued at $49 ..preclinicals only Light years from phase 3 Neutral…PT …$30

NakadasuTellaria Posted - 10/28/24

Stifel Nicolaus Trims NXP Semiconductors ( $NXPI) Target Price to $260.00 Morgan Stanley Trims Boeing ( $BA) Target Price to $170.00 Helmerich & Payne, Inc. ( $HP) Receives $40.88 Consensus Target Price from Brokerages WIMI Hologram Cloud( $WIMI) had $5.00 Average Target Price from Evaluate Research Kymera Therapeutics, Inc. ( $KYMR) Receives $49.00 Consensus Target Price from Analysts

briefingcom Posted - 10/24/24

$KYMR: Kymera Therapeutics announces that it recently initiated dosing in the Phase 1 clinical trial in the US evaluating KT-621, a potent, selective, oral degrader of STAT6, in adult healthy volunteers https://www.briefing.com/in-depth-analysis/content/article?ArticleId=IN20241024070805KYMR&utm_campaign=inplay&utm_medium=social&utm_source=st&utm_content=view_page

Tumble51 Posted - 1 month ago

$ALNY $KYMR $RYTM $CADL …yes the tts hit their premiums yesterday, without roll up and now, they play no more !!! Typical 3rd week of the month here Add $QURE to the list , lol. “ patent “ over “ truth “ ( ya right , left with your draws down )

MaverikIT Posted - 1 month ago

@IsabellaDC @net0trader $RACE +8.18 day for $SOXL $KYMR

Tumble51 Posted - 1 month ago

$KYMR thought so !!! So like able !!!

LongtermZ94 Posted - 1 month ago

The FDA Clears Kymera Therapeutics' $KYMR Investigational New Drug Application For KT-621, The Company Expects To Initiate Dosing In A Phase 1 Trial In Healthy Volunteers In October 2024 And To Report Data In The First Half Of 2025 $KYMR $QQQ

themacromindset Posted - 1 month ago

Kymera Therapeutics Announces FDA Clearance of Investigational New Drug Application for KT-621, a First-in-Class, Oral STAT6 Degrader $KYMR

Tumble51 Posted - 09/26/24

$KYMR ya, in 2040

oparide Posted - 09/25/24

$KYMR is $54 range in sight?

Tumble51 Posted - 09/25/24

$KYMR Data NEXT year of Phase 1 .holy snike- ees and 3B I see another round of money needed

DonCorleone77 Posted - 09/25/24

$KYMR Kymera Therapeutics presents data for KT-621 at EADV Congress Kymera Therapeutics announced the presentation of preclinical data for KT-621, a potent, selective, oral degrader of STAT6, an essential transcription factor that is a central driver of TH2 inflammation. The featured data highlight the differentiated profile of KT-621 as a potential once daily, oral treatment for TH2 driven allergic and atopic diseases. The data were presented at the European Academy of Dermatology and Venereology, EADV, Congress being held September 25-28, 2024, in Amsterdam, Netherlands. The Company has completed IND-enabling studies and intends to initiate Phase 1 testing for KT-621 in the second half of 2024, with data from the Phase 1 trial expected to be reported in the first half of 2025. KT-621 demonstrated strong degradation of STAT6 in human sensory neurons resulting in inhibition of IL-13-induced itch- and pain-related gene transcripts with the potential to alleviate these symptoms in atopic dermatitis patients

Stock_Titan Posted - 09/25/24

$KYMR Kymera Therapeutics Presents Preclinical Data for KT-621, a Potent, Selective, First-In-Class, Oral STAT6 Degrader at the EADV Congress https://www.stocktitan.net/news/KYMR/kymera-therapeutics-presents-preclinical-data-for-kt-621-a-potent-p5i82llkja5v.html

Wrangler4 Posted - 09/24/24

$KYMR Ah that’s why it is up…helping an insider the fcuk out

Wrangler4 Posted - 09/24/24

$KYMR doing better than $RYTM and no drug in sight for at least 5 years…phase 1/1a isn’t even enrolled fully …what bozos paying up for this ….hell, RYTM has an approved drug already !!!

Epawlow8 Posted - 09/24/24

$KYMR 2x wolf mode as seen today-My sell orders set @ $62

MaverikIT Posted - 09/24/24

@IsabellaDC @net0trader $KYMR +2.04 - been good

Wrangler4 Posted - 09/23/24

$KYMR BFD ..what, preclinical only, hahaha ..No, Phase 1/2 data ?

FlynancialAnalyst Posted - 09/22/24

$KYMR $3.17B mc founder-led $XBI name with a 2.5yr+ high wkly close on volume Potential #ShortSqueeze candidate as as short float % continues to fall to 6 mo. lows TrendEdge.app/asset/KYMR

insiderbuyingselling Posted - 2 months ago

$KYMR new insider selling: 13500 shares. http://insiderbuyingselling.com/?t=KYMR

MikeyNJ Posted - 2 months ago

$KYMR Wrangler4 and Tumble51 is the same knucklehead who has been posting nonsense here for months. This puerile individual creates multiple aliases and apparently gets enjoyment writing the same uneducated drivel over and over. He spewed the same hackneyed rhetoric when the stock was $13. The recent capital raise was not any type of promo. The company wasn't even looking to raise. The Baker Brother's wanted to increase their stake and they were proactive initiating the deal. If you already own KYMR just hold on to those shares for the long run. The multiple alias guy here knows nothing.

MaverikIT Posted - 2 months ago

@IsabellaDC @net0trader @RonIsWrong $KYMR